25.04.13
APPG launches pancreatic cancer inquiry
The all party parliamentary group on pancreatic cancer has launched an inquiry into survival rates for the disease.
The survival rate for pancreatic cancer is currently at around 4% – the lowest of the 21 most common cancers in the UK. The APPG will consider the importance of early diagnosis, and why the UK is lagging behind many other EU countries on pancreatic cancer survival.
The first evidence session will be held on May 16, and hear from patients, families and carers. You can submit evidence here.
Eric Ollerenshaw MP OBE, secretary, APPG on pancreatic cancer, said: “I welcome the launch of this Inquiry into pancreatic cancer survival rates. As someone who has lost a partner due to pancreatic cancer, I hope that patients, carers, GPs, clinicians and health managers will participate, and together we can improve survival rates.”
Clara MacKay, acting chief executive of Pancreatic Cancer UK, commented: “Survival rates for pancreatic cancer have hardly changed in the last 40 years which means that this inquiry is long overdue. We greatly welcome the efforts of the APPG on pancreatic cancer to shine a light on this disease and the reasons why the 8,350 people diagnosed each year have such poor survival rates, compared to almost any other cancer patient group.”
Tell us what you think – have your say below, or email us directly at [email protected]